DataMEDS AI, Inc. (MEDS)
NASDAQ: MEDS · Real-Time Price · USD
3.580
-4.010 (-52.83%)
At close: Jul 22, 2026, 4:00 PM EDT
3.440
-0.140 (-3.91%)
Pre-market: Jul 23, 2026, 5:35 AM EDT

DataMEDS AI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
940---
Market Cap Growth
38.31%----
Enterprise Value
37.6665.01000
PS Ratio
0.641.73---
PB Ratio
-0.41---
P/TBV Ratio
0.080.39---
EV/Sales Ratio
2.682.79---
Debt / Equity Ratio
0.190.130.76-0.120.59
Net Debt / Equity Ratio
0.280.251.45-0.120.80
Net Debt / EBITDA Ratio
-0.44-0.27-4.76-0.12-7.11
Net Debt / FCF Ratio
-6.30-2.26-19.57-1.00-268.64
Asset Turnover
0.460.530.6301.57
Inventory Turnover
12.525.343.4403.12
Quick Ratio
0.030.040.130.120.56
Current Ratio
0.090.090.400.121.53
Return on Equity (ROE)
-75.72%-176.01%-100.89%-133.49%3.92%
Return on Assets (ROA)
-225.84%-213.57%-21.31%-27.91%-5.89%
Return on Invested Capital (ROIC)
-166.46%-200.09%-22.50%-44.20%-9.17%
Return on Capital Employed (ROCE)
9830.94%-939.12%-73.44%-64.30%-10.38%
Payout Ratio
-0.00%0.00%0.00%604.83%
Buyback Yield / Dilution
-71.58%-50.23%-5.66%--
Total Shareholder Return
-71.58%-50.23%-5.66%--